← Leaderboards
Lawrence Zisman
Pulmokine, Inc.
$1,778,390
Attributed
$1,778,390
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $695.6K · FY2013–16$1M$750K$500K$250K$0
'13
'14
'15
'16
Funding mix
By agency
NIH$1,778,390 · 2
By mechanism
N01$1,553,430 · 1
N43$224,960 · 1
Top collaborators
No co-investigators on record.
Most similar at Pulmokine, Inc.
Same institution · by research overlap
- Jeffrey Breit$1,136,252
- Ravikumar Sitapara$515,573
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsAdverse EffectsProduct DevelopmentProgramsPulmonary Arterial HypertensionPulmonary HypertensionSeriesStagingSupport ContractsTechnologyVascular DiseasesBlood VesselsBone Marrow SuppressionBreathingContractsDiagnosticEdemaGastrointestinalInhibitor/AntagonistInnovationMedicalModalityNational Heart, Lung, And Blood InstituteNovel Therapeutic Intervention
Grant awards (4)
IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances (VITA): IND Enabling Studies for a Novel Inhaled PDGF Receptor Inhibitor to Treat PAH$618,547
N01 · FY2016 · HL · contact PI
IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances (VITA): IND Enabling Studies for a Novel Inhaled PDGF Receptor Inhibitor to Treat PAH$695,615
N01 · FY2015 · HL · contact PI
IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances (VITA): IND Enabling Studies for a Novel Inhaled PDGF Receptor Inhibitor to Treat PAH$239,268
N01 · FY2014 · HL · contact PI
IGF::OT::IGF Aerosolized Delivery of Anti-Tubercular Drugs$224,960
N43 · FY2013 · AI · contact PI